Novavax, Inc. (NVAX) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
NVAX Historical Performance
Short-Term Returns
NVAX Stock Price Trajectory (2011–2026)
As of May 6, 2026, Novavax, Inc. (NVAX) trades at $9.36, representing a +54.2% return over the past year. The stock has delivered a -94.6% total return over five years (-44.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $331.68 on February 9, 2021. From this peak, NVAX has corrected -97.2%, currently trading 14% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers MRNA (+99.7% 1Y), BNTX (+0.5% 1Y), and PFE (+15.8% 1Y), NVAX has underperformed the peer group average. Compare NVAX vs MRNA →
NVAX Historical Price Data (2011–2026)
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 8.56 | 9.56 | 8.35 | 9.36 | 16.00M | +15.41% |
| 2026-05-05 | 8.10 | 8.16 | 7.81 | 8.11 | 3.46M | +1.00% |
| 2026-05-04 | 8.09 | 8.36 | 7.96 | 8.03 | 2.09M | -0.12% |
| 2026-05-01 | 7.90 | 8.08 | 7.86 | 8.04 | 2.98M | +1.45% |
| 2026-04-30 | 8.01 | 8.27 | 7.92 | 7.92 | 2.80M | -0.56% |
| 2026-04-29 | 7.83 | 7.99 | 7.71 | 7.97 | 2.78M | +0.63% |
| 2026-04-28 | 8.04 | 8.10 | 7.87 | 7.92 | 3.19M | -1.86% |
| 2026-04-27 | 8.17 | 8.33 | 7.97 | 8.07 | 2.59M | -1.82% |
| 2026-04-24 | 8.21 | 8.29 | 8.06 | 8.22 | 1.69M | +0.86% |
| 2026-04-23 | 8.43 | 8.51 | 7.97 | 8.15 | 3.57M | -3.55% |
| 2026-04-22 | 8.54 | 8.65 | 8.40 | 8.45 | 3.52M | -0.47% |
| 2026-04-21 | 8.67 | 8.74 | 8.41 | 8.49 | 3.91M | -2.08% |
| 2026-04-20 | 8.73 | 8.85 | 8.60 | 8.67 | 2.71M | -1.92% |
| 2026-04-17 | 8.88 | 8.99 | 8.75 | 8.84 | 2.35M | +2.31% |
| 2026-04-16 | 8.79 | 8.80 | 8.46 | 8.64 | 1.98M | -0.58% |
| 2026-04-15 | 8.39 | 8.79 | 8.38 | 8.69 | 2.95M | +3.58% |
| 2026-04-14 | 8.21 | 8.40 | 8.13 | 8.39 | 2.98M | +3.45% |
| 2026-04-13 | 8.08 | 8.31 | 7.99 | 8.11 | 2.72M | -0.12% |
| 2026-04-10 | 8.52 | 8.55 | 8.02 | 8.12 | 3.37M | -4.92% |
| 2026-04-09 | 8.41 | 8.60 | 8.32 | 8.54 | 2.26M | +1.43% |
| 2026-04-08 | 8.47 | 8.60 | 8.18 | 8.42 | 3.68M | +5.51% |
| 2026-04-07 | 7.80 | 8.04 | 7.71 | 7.98 | 2.24M | +0.13% |
| 2026-04-06 | 7.78 | 8.13 | 7.78 | 7.97 | 2.79M | +3.51% |
| 2026-04-02 | 7.62 | 7.91 | 7.57 | 7.70 | 4.60M | -3.99% |
| 2026-04-01 | 8.20 | 8.32 | 8.00 | 8.02 | 2.78M | -1.47% |
| 2026-03-31 | 8.27 | 8.39 | 7.71 | 8.14 | 5.86M | +0.62% |
| 2026-03-30 | 8.38 | 8.42 | 7.94 | 8.09 | 4.08M | -4.26% |
| 2026-03-27 | 8.84 | 8.96 | 8.45 | 8.45 | 3.85M | -5.59% |
| 2026-03-26 | 8.97 | 9.29 | 8.75 | 8.95 | 3.01M | -4.18% |
| 2026-03-25 | 9.39 | 9.60 | 9.22 | 9.34 | 2.65M | +0.86% |
See NVAX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVAX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVAX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVAX — Frequently Asked Questions
Quick answers to the most common questions about buying NVAX stock.
How has NVAX stock performed recently?
NVAX returned +54.2% over the past year, beating its 5-year annualized CAGR of -44.2%. The stock trades above its 200-day moving average, confirming the uptrend.
What is NVAX's all-time high price?
Novavax, Inc. reached $331.68 on 2021-02-09. The 52-week high is $11.97. Current 1-year return of +54.2% places the stock closer to historical peaks.
Where can I download NVAX historical price data?
This page provides NVAX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.